Jefferies Group's EVH Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 291,600 shares of Evolent Health, Inc. (EVH) worth $664,848, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in EVH, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 271,780 shares. Largest reduction occurred in Q3 2025, reducing 460,060 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Evolent Health (EVH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evolent Health (EVH) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +271,780 | Add 1371.24% | 291,600 | $4.00 |
| Q3 2025 | -460,060 | Reduce 95.87% | 19,820 | $8.46 |
| Q2 2025 | +149,070 | Add 45.06% | 479,880 | $11.26 |
| Q1 2025 | +75,810 | Add 29.73% | 330,810 | $9.47 |
| Q4 2024 | +187,180 | Add 276.00% | 255,000 | $11.25 |
| Q3 2024 | -108,793 | Reduce 61.60% | 67,820 | $28.28 |
| Q2 2024 | +175,537 | Add 16313.85% | 176,613 | $19.12 |
| Q1 2024 | -8,674 | Reduce 88.96% | 1,076 | $32.79 |
| Q4 2023 | -22,466 | Reduce 69.74% | 9,750 | $33.03 |
| Q3 2023 | -28,138 | Reduce 46.62% | 32,216 | $27.23 |
| Q2 2023 | +24,045 | Add 66.22% | 60,354 | $30.30 |
| Q1 2023 | -4,593 | Reduce 11.23% | 36,309 | $32.45 |
| Q4 2022 | +40,902 | New Buy | 40,902 | $28.08 |
Jefferies Group's Evolent Health Investment FAQs
Jefferies Group first purchased Evolent Health, Inc. (EVH) in Q4 2022, acquiring 40,902 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Evolent Health, Inc. (EVH) for 14 quarters since Q4 2022.
Jefferies Group's largest addition to Evolent Health, Inc. (EVH) was in Q4 2025, adding 291,600 shares worth $1.17 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 291,600 shares of Evolent Health, Inc. (EVH), valued at approximately $664,848.
As of the Q1 2026 filing, Evolent Health, Inc. (EVH) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Evolent Health, Inc. (EVH) was 479,880 shares, as reported at the end of Q2 2025.